Scarica l'app Stockscreener
437.85
0.16%
0.68
Pre-mercato:
433.00
-4.85
-1.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
Using Python tools to backtest Madrigal Pharmaceuticals Inc. strategiesJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
Analyzing Madrigal Pharmaceuticals Inc. with risk reward ratio chartsWeekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
How to manage a losing position in Madrigal Pharmaceuticals Inc.July 2025 Rallies & Verified Momentum Stock Ideas - Newser
Should you wait for a breakout in Madrigal Pharmaceuticals Inc.2025 Key Highlights & Capital Protection Trading Alerts - Newser
Can Madrigal Pharmaceuticals Inc. maintain sales growth2025 Earnings Impact & Daily Profit Focused Stock Screening - خودرو بانک
How to forecast Madrigal Pharmaceuticals Inc. trends using time seriesPortfolio Update Summary & Smart Investment Allocation Insights - Newser
What machine learning models say about Madrigal Pharmaceuticals Inc.July 2025 Big Picture & Trade Opportunity Analysis - Newser
Trend analysis for Madrigal Pharmaceuticals Inc. this weekWatch List & Daily Chart Pattern Signals - Newser
Should you wait for a breakout in Madrigal Pharmaceuticals Inc2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Is Madrigal Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser
Key metrics from Madrigal Pharmaceuticals Inc.’s quarterly data2025 Analyst Calls & Risk Managed Investment Signals - Newser
Forecasting Madrigal Pharmaceuticals Inc. price range with options dataWeekly Stock Recap & Growth Focused Entry Reports - Newser
Intraday pattern recognizer results for Madrigal Pharmaceuticals Inc.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
What momentum shifts mean for Madrigal Pharmaceuticals Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - Newser
Backtesting results for Madrigal Pharmaceuticals Inc. trading strategiesProfit Target & Low Risk High Win Rate Stock Picks - Newser
Analyzing net buyer seller activity in Madrigal Pharmaceuticals Inc.July 2025 Movers & Comprehensive Market Scan Insights - Newser
What to expect from Madrigal Pharmaceuticals Inc. in the next 30 daysQuarterly Growth Report & Consistent Profit Trading Strategies - Newser
Developing predictive dashboards with Madrigal Pharmaceuticals Inc. dataTrade Volume Report & Daily Technical Stock Forecast Reports - Newser
Is a relief rally coming for Madrigal Pharmaceuticals Inc. holders2025 Technical Overview & Safe Entry Zone Identification - Newser
Published on: 2025-08-31 13:52:27 - Newser
Will Madrigal Pharmaceuticals Inc. stock go up soon2025 Historical Comparison & Stock Portfolio Risk Management - Newser
Leerink Partners Maintains a Buy on Madrigal Pharmaceuticals (MDGL), Here’s Why - MSN
How sentiment analysis helps forecast Madrigal Pharmaceuticals Inc.2025 Market Overview & Growth Focused Investment Plans - Newser
Madrigal Pharmaceuticals Inc. Shows Support at Fibonacci LevelQuarterly Trade Report & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Earnings visualization tools for Madrigal Pharmaceuticals Inc.July 2025 Opening Moves & Safe Entry Point Alerts - Newser
Published on: 2025-08-30 05:07:56 - Newser
Will Madrigal Pharmaceuticals Inc. see short term momentum2025 Biggest Moves & Short-Term Trading Alerts - Newser
Price action breakdown for Madrigal Pharmaceuticals Inc.Quarterly Earnings Summary & Capital Efficient Trading Techniques - Newser
Real time pattern detection on Madrigal Pharmaceuticals Inc. stock2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Earnings visualization tools for Madrigal Pharmaceuticals Inc2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Identifying reversal signals in Madrigal Pharmaceuticals Inc.July 2025 Update & Short-Term High Return Ideas - Newser
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):